Matteson E L, Gold K N, Bloch D A, Hunder G G
Division of Rheumatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Am J Med. 1996 Feb;100(2):193-6. doi: 10.1016/s0002-9343(97)89458-2.
To characterize survivorship among patients with giant cell arteritis in a well-defined, multicenter cohort.
Follow-up was obtained for 205 (95.8%) of the 214 patients enrolled in the 1990 American College of Rheumatology vasculitis classification study. Standardized mortality ratios (SMR) were calculated comparing mortality data from this group of patients with giant cell arteritis versus the general population.
There were 49 deaths (33 women and 16 men among the 205 patients available for follow-up. Survivorship was virtually identical to that of the general population (SMR = 1.034 +/- 0.121), and was similar for women (SMR = 1.022 +/- 0.149) and men (SMR = 1.078 +/- 0.206) (SMR = 1 indicates that expected and observed survival are identical).
The life expectancy of patients with giant cell arteritis is the same as that of the general population.
在一个明确界定的多中心队列中，对巨细胞动脉炎患者的生存情况进行特征描述。
对1990年美国风湿病学会血管炎分类研究中登记入组的214例患者中的205例（95.8%）进行了随访。计算标准化死亡比（SMR），将该组巨细胞动脉炎患者的死亡率数据与普通人群进行比较。
在可供随访的205例患者中有49例死亡（33例女性和16例男性）。生存率与普通人群几乎相同（SMR = 1.034 ± 0.121），女性（SMR = 1.022 ± 0.149）和男性（SMR = 1.078 ± 0.206）的情况相似（SMR = 1表明预期生存与观察到的生存相同）。
巨细胞动脉炎患者的预期寿命与普通人群相同。
